» Download Public Reports
About 900 reports
- Country report
- March 2013
- 40 pages
... Products with a strong manufacturing base. India continues to gain traction as one of the most prominent countries with an exceptional capability to act as a sourcing point for quality generic medicines ...
April 2013
... In antiretroviral drugs being led by companies such as gilead. In 2011, hiv drugs accounted for $6.4 Billion gilead S sales and they continue to improve treatment in this area. They also appear to be leading ...
April 2013
... Hexyontm/hexacima complements sanofi pasteur S product family of acp-ipv (acellular pertussis vaccine, inactivated poliovirus vaccine) combination vaccines. The new 6-in-1 vaccine will be available ...
March 2013
... hydroquinone Highly toxic to skin and linked to cancer Unstable Banned in several countries Major adverse events monobenzyl ether of hydroquinone or monobenzone (mbeh) Nearly irreversible ...
May 2013
... Government organised a public tender for the hpv vaccines. This tender led to price reductions from 375 To 52. 53 Stroetmann k. A., Jones t ...
March 2013
... Care consumers and patientsinsurance and risk carriers consumer demand demand for medicines key questions: Does household making on care seeking and treatment differ by gender Can ...
April 2013
... Doses, higher doses, wrong time, not with food, etc.) Tertiary non-adherence (non-persistence) When a patient elects to stop taking prescription medication without consulting his/her prescriber ...
April 2013
... Equity of access on paper but weak 1010 20/04/2013 harm reduction as a policy pillar is: Rejected by nigeria; Included in 2012-16 drug master plan of so africa but defined as achieved through treatment ...
May 2013
... Of a polio vaccine what does it take to vaccinate a child against polio This two-minute video from unicef shows us that the journey of a polio vaccine is an incredibly complex process. The menafrivac ctc ...
» Purchase Premium Reports
(From $ 250 - $ 10 988)
About 1 100 reports
- $ 11 691
- Industry report
- May 2013
- by Global Research & Data Services
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different European countries. The studies provide essential market information ...
May 2013
$ 10 494
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Asian countries. The studies provide essential market information ...
May 2013
$ 7 701
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different Eastern European countries. The studies provide essential market ...
May 2013
$ 5 174
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in the top 10 global countries. The studies provide essential market information ...
November 2013
$ 4 395
This report is an effort to identify factors, which will be the driving force for the infertility drugs and devices market and sub-markets in the next few years. The report provides an extensive analysis ...
March 2013
$ 3 995
PharmaFocus: Vaccine Adjuvants in Infectious Disease Summary Originally discovered by Glenny in the 1920s, vaccine adjuvants have remained the pharmaceutical industry's ?dirty little secret?. Today, ...
May 2013
$ 4 110
This market research report package offers a perspective on the actual market situation, trends and future outlook for vaccines in different African countries. The studies provide essential market information ...